Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (161-170 of 500) with videos related to

Pageof 50
Sort By:
Journal of the National Cancer Institute|August 18, 2022
Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell TransplantationRusha Bhandari, Jennifer Berano Teh, Tianhui He, et al.
Cancer Research|April 20, 2011
Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levelsLeo Kretzner, Anna Scuto, Pamela M Dino, et al.
British Journal of Haematology|October 13, 2015
Breast implants and anaplastic large cell lymphomas among females in the California Teachers Study cohortSophia S Wang, Dennis Deapen, Jenna Voutsinas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Late congestive heart failure after hematopoietic cell transplantationSaro H Armenian, Can-Lan Sun, Liton Francisco, et al.
Blood|June 10, 2011
A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cellsXiuli Wang, Wen-Chung Chang, ChingLam W Wong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2019
Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria ClonesMatthew Mei, Rohan Gupta, Margaret O'Donnell, et al.
Leukemia & Lymphoma|February 29, 2012
Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failureNitya Nathwani, Amrita Y Krishnan, Qin Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membraneScott E James, Philip D Greenberg, Michael C Jensen, et al.
Transplantation|August 27, 2019
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA MismatchMonzr M Al Malki, Ketevan Gendzekhadze, Dongyun Yang, et al.
Blood Advances|June 17, 2024
Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignanciesZhengyuan Dong, L Elizabeth Budde, Elizabeth Oh, et al.
Pageof 50

Showing results (161-170 of 500) with videos related to

Sort By:
Pageof 50
Journal of the National Cancer Institute|August 18, 2022
Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell TransplantationRusha Bhandari, Jennifer Berano Teh, Tianhui He, et al.
Cancer Research|April 20, 2011
Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levelsLeo Kretzner, Anna Scuto, Pamela M Dino, et al.
British Journal of Haematology|October 13, 2015
Breast implants and anaplastic large cell lymphomas among females in the California Teachers Study cohortSophia S Wang, Dennis Deapen, Jenna Voutsinas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Late congestive heart failure after hematopoietic cell transplantationSaro H Armenian, Can-Lan Sun, Liton Francisco, et al.
Blood|June 10, 2011
A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cellsXiuli Wang, Wen-Chung Chang, ChingLam W Wong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2019
Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria ClonesMatthew Mei, Rohan Gupta, Margaret O'Donnell, et al.
Leukemia & Lymphoma|February 29, 2012
Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failureNitya Nathwani, Amrita Y Krishnan, Qin Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membraneScott E James, Philip D Greenberg, Michael C Jensen, et al.
Transplantation|August 27, 2019
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA MismatchMonzr M Al Malki, Ketevan Gendzekhadze, Dongyun Yang, et al.
Blood Advances|June 17, 2024
Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignanciesZhengyuan Dong, L Elizabeth Budde, Elizabeth Oh, et al.
Pageof 50